Life Technologies Partners with Beijing Genomics Institute (BGI) on Human Genome Sequencing
CARLSBAD, Calif. & SHENZHEN, China--(BUSINESS WIRE)--Life Technologies Corporation (NASDAQ: LIFE) and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world’s largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.